Form 4 for IBRX ImmunityBio, Inc.
Accepted 2023-06-16 00:00:00 ET · period of report 2023-06-15 · accession 0001326110-23-000092 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-16 | 2023-06-15 | IBRX | LAUER REGAN J | CAO | M - OptEx | $0.00 | +21.0K | 21.0K | New | $0 |
| D | 2023-06-16 | 2023-06-15 | IBRX | LAUER REGAN J | CAO | M - OptEx | $0.00 | -21.0K | 42.1K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-15 | M | A | 21,030 | $0.00 | 21,030 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of ImmunityBio, Inc. common stock. |
| 2 | Derivative | Restricted Stock Units | 2023-06-15 | M | D | 21,030 | $0.00 | 42,061 | D | — · — to — | 21,030 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of ImmunityBio, Inc. common stock. (F2) Subject to the reporting person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through each applicable vesting date, the restricted stock units ("RSUs") will vest as follows: 1/3rd of the RSUs subject to the award shall vest June 15, 2023, 1/3rd of the RSUs subject to the award shall vest December 15, 2023, and 1/3rd of the RSUs subject to the award shall vest December 15, 2024 such that the award shall be fully vested on December 15, 2024. |